Procurement Summary
Country: USA
Summary: Dow Ovarian Cancer, Clinical Trial Award
Deadline: 01 Oct 2026
Posting Date: 05 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140656040
Document Ref. No.: HT942526OCRPCTA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
75100000 - Administration services
85100000 - Health services
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Summary: The Ocrp Clinical Trial Award Supports The Rapid Implementation Of Clinical Trials With The Potential To Have A Significant Impact On The Treatment Or Management Of Ovarian Cancer.Distinctive Features: Clinical Trials May Be Designed To Evaluate Promising New Products, Pharmacologic Agents (Drugs Or Biologics), Devices, Clinical Guidance And/Or Emerging Approaches And Technologies. Proposed Projects May Range From Small Proof-Of-Concept Trials (E.G., Pilot, First-In-Human, Phase 0) To Demonstrate The Feasibility Or Inform The Design Of More Advanced Trials Through Large-Scale Trials To Determine Efficacy In Relevant Patient Populations.Eligibilityeligible Applicantsmiscellaneousunrestrictedadditional Informationgrantor Contact Informationdescriptionebrap Help Desk Phone: 301-682-5507 Email: [email protected] Help Deskdocumentsfile Namedescriptionlast Updatedfy26 Ocrp Cta Program Announcementmay 4, 2026 04:19 Pm Utcocrp Reference Tablemay 4, 2026 04:19 Pm Utclink To Additional Information--Closing: October 1, 2026
Posted Date: 2026-05-04 00:00:00
Funding instrument type: Grant
Documents
Tender Notice